Role of tixagevimab-cilgavimab in preventing SARS-CoV-2 in hematopoietic stem cell transplant and chimeric antigen receptor T-cell therapy recipients.

Aswani ThurlapatiMary McGannJames A DavisKatelynn GrangerKiera RoubalDeidra SmithKelly J GaffneyAlyssa CendagortaAmanda HerbstLindsey HendricksonBrian T HessHamza Hashmi

Published in: Journal of medical virology (2023)

Keyphrases

cell therapy
hematopoietic stem cell
sars cov
respiratory syndrome coronavirus
stem cells
mesenchymal stem cells
kidney transplantation